{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:26:39Z","timestamp":1779337599869,"version":"3.51.4"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s11033-022-08113-6","type":"journal-article","created":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T18:02:52Z","timestamp":1670954572000},"page":"1857-1869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Neuroinflammation and neovascularization in diabetic eye diseases (DEDs): identification of potential pharmacotherapeutic targets"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6980-6761","authenticated-orcid":false,"given":"Siva Prasad","family":"Panda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P Hemachandra","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uma Sankar","family":"Gorla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DSNBK","family":"Prasanth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"8113_CR1","unstructured":"Thomas J (2020) Maitri NGO, New Delhi. Widows in India: Invisible women facing invisible problems \u2013 About Health and Sustainability. https:\/\/joethomas.in \u203a archives \u203a 906"},{"issue":"4","key":"8113_CR2","first-page":"34","volume":"3","author":"R Dave","year":"2020","unstructured":"Dave R (2020) Widowhood: the problems and challenges faced by widows in India. Int J Adv Res in Commer Manag & Soc Sci (IJARCMSS) 3(4):34\u201336","journal-title":"Int J Adv Res in Commer Manag & Soc Sci (IJARCMSS)"},{"issue":"7","key":"8113_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.24327\/IJRSR","volume":"8","author":"BUR Sharma","year":"2017","unstructured":"Sharma BUR (2017) A Comparative Analysis of Widows and Widowers in India. Int J Recent Scientific Res 8(7):69\u201373. https:\/\/doi.org\/10.24327\/IJRSR","journal-title":"Int J Recent Scientific Res"},{"issue":"43\/44","key":"8113_CR4","first-page":"Ws81","volume":"27","author":"MA Chen","year":"1992","unstructured":"Chen MA, Dreze J (1992) Widows and health in rural North India. Econ Pol Wkly 27(43\/44):Ws81\u201392","journal-title":"Econ Pol Wkly"},{"key":"8113_CR5","unstructured":"Anon (2017) Old widows in Vrindavan have hypertension, and other problems find a survey. (sakshi.com), November 26, 2017"},{"key":"8113_CR6","first-page":"546","volume":"7","author":"S Valarmathi","year":"2020","unstructured":"Valarmathi S, Vijayabhanu R (2020) A review on diabetic retinopathy disease detection and classification using image processing techniques. IRJET 7:546\u2013555","journal-title":"IRJET"},{"key":"8113_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4239\/wjd.v1.i1.12","volume":"1","author":"GI Liou","year":"2010","unstructured":"Liou GI (2010) Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation. World J Diabetes 1:12\u201318","journal-title":"World J Diabetes"},{"key":"8113_CR8","doi-asserted-by":"publisher","first-page":"15209","DOI":"10.1007\/s11042-018-7044-8","volume":"79","author":"U Ishtiaq","year":"2020","unstructured":"Ishtiaq U, Abdul Kareem S, Abdullah ERMF, Mujtaba G, Jahangir R, Ghafoor HY (2020) Diabetic retinopathy detection through artificial intelligent techniques: a review and open issues. Multimed Tools Appl 79:15209\u201315252","journal-title":"Multimed Tools Appl"},{"key":"8113_CR9","doi-asserted-by":"crossref","unstructured":"Emon MU, Zannat R, Khatun T, Rahman M, Keya MS, Ohidujjaman (2021) Performance Analysis of Diabetic Retinopathy Prediction using Machine Learning Models, 6th International Conference on Inventive Computation Technologies (ICICT) 2021: 1048\u20131052","DOI":"10.1109\/ICICT50816.2021.9358612"},{"key":"8113_CR10","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.2337\/dc12-1801","volume":"35","author":"MS Kirkman","year":"2012","unstructured":"Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB et al (2012) Diabetes in Older Adults. Diabetes Care 35:2650\u20132664","journal-title":"Diabetes Care"},{"issue":"2","key":"8113_CR11","first-page":"25","volume":"1","author":"D Agarwal","year":"2017","unstructured":"Agarwal D, Bansal A (2017) Non-invasive techniques for the screening of diabetic retinopathy. J Biomed Imag Bioeng 1(2):25\u201330","journal-title":"J Biomed Imag Bioeng"},{"key":"8113_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2147\/OPTH.S236637","volume":"14","author":"SE Mansour","year":"2020","unstructured":"Mansour SE, Browning DJ, Wong K, Flynn HW Jr, Bhavsar AR (2020) The evolving treatment of diabetic retinopathy. Clin Ophthalmol 14:653\u2013678","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"8113_CR13","first-page":"2303","volume":"9","author":"J Cao","year":"2019","unstructured":"Cao J, Wang J, He C, Fang M (2019) Angiosarcoma: a review of diagnosis and current treatment. Am J Cancer Res 9(11):2303\u20132313","journal-title":"Am J Cancer Res"},{"key":"8113_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000431129","volume":"55","author":"RG Rubio","year":"2016","unstructured":"Rubio RG, Adamis AP (2016) Ocular Angiogenesis: Vascular Endothelial Growth Factor and Other Factors. Dev Ophthalmol 55:28\u201337","journal-title":"Dev Ophthalmol"},{"issue":"Suppl 6","key":"8113_CR15","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/mds.10559","volume":"18","author":"MJ Mart\u00ed","year":"2003","unstructured":"Mart\u00ed MJ, Tolosa E, Campdelacreu J (2003) Clinical overview of the synucleinopathies. Mov Disord 18(Suppl 6):S21\u2013S27. doi: https:\/\/doi.org\/10.1002\/mds.10559","journal-title":"Mov Disord"},{"key":"8113_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2746\/095777308X313971","volume":"207","author":"AS Bischofberger","year":"2008","unstructured":"Bischofberger AS, Konar M, Posthaus H, Pekarkova M, Grzybowski M, Brehm W (2008) Ocular angiosarcoma in a pony - MRI and histopathological appearance. Equine Veterinary Education 207:340\u2013347","journal-title":"Equine Veterinary Education"},{"key":"8113_CR17","unstructured":"Rohilla A, Kumar R, Rohilla S, Kushknoor A (2012) Diabetic Retinopathy: origin and complications. Euro J Exp Bio 2012: 88\u201394"},{"key":"8113_CR18","doi-asserted-by":"publisher","unstructured":"Amin J, Sharif M, Yasmin M (2016) A Review on Recent Developments for Detection of Diabetic Retinopathy. Scientifica (Cairo) 2016: 6838976. doi: https:\/\/doi.org\/10.1155\/2016\/6838976","DOI":"10.1155\/2016\/6838976"},{"key":"8113_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1573399815666190510112035","volume":"16","author":"A Shakya","year":"2020","unstructured":"Shakya A, Chaudary SK, Garabadu D, Bhat HR, Kakoti BB, Ghosh SK (2020) A Comprehensive review on preclinical diabetic models. Curr Diabetes Rev 16:104\u2013116. doi: https:\/\/doi.org\/10.2174\/1573399815666190510112035","journal-title":"Curr Diabetes Rev"},{"issue":"9","key":"8113_CR20","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.3390\/pharmaceutics13091376","volume":"13","author":"A Dammak","year":"2021","unstructured":"Dammak A, Huete-Toral F, Carpena-Torres C, Martin-Gil A, Pastrana C, Carracedo G (2021) From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment. Pharmaceutics 13(9):1376","journal-title":"Pharmaceutics"},{"key":"8113_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/2042018810396750","volume":"2","author":"CP Shah","year":"2011","unstructured":"Shah CP, Chen C (2011) Review of therapeutic advances in diabetic retinopathy. Ther Adv Endocrinol Metab 2:39\u201353","journal-title":"Ther Adv Endocrinol Metab"},{"key":"8113_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","volume":"237","author":"U Schmidt-Erfurth","year":"2017","unstructured":"Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U et al (2017) Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237:185\u2013222","journal-title":"Ophthalmologica"},{"key":"8113_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","volume":"2","author":"R Lee","year":"2015","unstructured":"Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye and Vis 2:17","journal-title":"Eye and Vis"},{"issue":"3","key":"8113_CR24","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/030098588602300303","volume":"23","author":"PF Moore","year":"1986","unstructured":"Moore PF, Hacker DV, Buyukmihci NC (1986) Ocular angiosarcoma in the horse: morphological and immunohistochemical studies. Vet Pathol 23(3):240\u2013244","journal-title":"Vet Pathol"},{"key":"8113_CR25","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1084\/jem.138.4.1015","volume":"138","author":"TS Zimmerman","year":"1973","unstructured":"Zimmerman TS, Edgington TS (1973) Factor VIII coagulant activity and factor VIII-like antigen: independent molecular entities. J Exp Med 138:1015\u20131020","journal-title":"J Exp Med"},{"issue":"1","key":"8113_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2009.02005.x","volume":"16","author":"V Terraube","year":"2010","unstructured":"Terraube V, O\u2019Donnell JS, Jenkins PV (2010) Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia 16(1):3\u201313","journal-title":"Haemophilia"},{"issue":"4","key":"8113_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S1567-5769(03)00002-X","volume":"3","author":"W Li","year":"2003","unstructured":"Li W, Keller GA (2003) An antibody to VEGF upregulates factor VIII via interleukin-1 in activated adrenal cortex-derived capillary endothelial cells. Int Immunopharmacol 3(4):493\u2013512. doi: https:\/\/doi.org\/10.1016\/S1567-5769(03)00002-X","journal-title":"Int Immunopharmacol"},{"key":"8113_CR28","first-page":"1703","volume":"41","author":"L Sobrin","year":"2000","unstructured":"Sobrin L, Liu Z, Monroy DC, Solomon A, Selzer MG, Lokeshwar BL, Pflugfelder SC (2000) Regulation of MMP-9 Activity in Human Tear Fluid and Corneal Epithelial Culture Supernatant. Investig Ophthalmol Vis Sci 41:1703\u20131709","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"8113_CR29","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/jphp.13272","volume":"72","author":"SP Panda","year":"2020","unstructured":"Panda SP, Panigrahy UP, Prasanth D, Gorla US, Guntupalli C, Panda DP (2020) A trimethoxy flavonoid isolated from stem extract of Tabebuia chrysantha suppresses angiogenesis in angiosarcoma. J Pharm Pharmacol 72:990\u2013999. https:\/\/doi.org\/10.1111\/jphp.13272","journal-title":"J Pharm Pharmacol"},{"key":"8113_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s43094-021-00359-4","volume":"7","author":"SP Panda","year":"2021","unstructured":"Panda SP, Panigrahy UP, Mallick SP et al (2021) Screening assessment of trimethoxy flavonoid and - (-)-epigallocatechin-3-gallate against formalin-induced arthritis in Swiss albino rats and binding properties on NF-\u03baB-MMP9 proteins. Futur J Pharm Sci 7:207. https:\/\/doi.org\/10.1186\/s43094-021-00359-4","journal-title":"Futur J Pharm Sci"},{"key":"8113_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/imm.12716","volume":"150","author":"JG Galletti","year":"2017","unstructured":"Galletti JG, Guzman M, Giordano MN (2017) Mucosal immune tolerance at the ocular surface in health and disease. Immunology 150:397\u2013407. doi: https:\/\/doi.org\/10.1111\/imm.12716","journal-title":"Immunology"},{"key":"8113_CR32","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.it.2018.08.007","volume":"39","author":"AH Hovav","year":"2018","unstructured":"Hovav AH (2018) Mucosal and Skin Langerhans Cells - Nurture Calls. Trends Immunol 39:788\u2013800. doi: https:\/\/doi.org\/10.1016\/j.it.2018.08.007","journal-title":"Trends Immunol"},{"key":"8113_CR33","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ni.2360","volume":"13","author":"Y Wang","year":"2012","unstructured":"Wang Y, Szretter KJ, Vermi W, Gilfillan S, Rossini C, Cella M et al (2012) IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat Immunol 13:753\u2013760. doi: https:\/\/doi.org\/10.1038\/ni.2360","journal-title":"Nat Immunol"},{"key":"8113_CR34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1002\/eji.201444606","volume":"45","author":"ED Foucher","year":"2015","unstructured":"Foucher ED, Blanchard S, Preisser L, Descamps P, Ifrah N, Delneste Y et al (2015) IL-34- and M-CSF-induced macrophages switch memory T cells into Th17 cells via membrane IL-1\u03b1. Eur J Immunol 45:1092\u20131102. doi: https:\/\/doi.org\/10.1002\/eji.201444606","journal-title":"Eur J Immunol"},{"key":"8113_CR35","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/jac\/dkaa114","volume":"75","author":"D Zhou","year":"2020","unstructured":"Zhou D, Dai SM, Tong Q (2020) COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother 75:1667\u20131670. doi: https:\/\/doi.org\/10.1093\/jac\/dkaa114","journal-title":"J Antimicrob Chemother"},{"key":"8113_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395:507\u2013513. doi: https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"Lancet"},{"issue":"11","key":"8113_CR37","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00277-017-3115-6","volume":"96","author":"YW Koh","year":"2017","unstructured":"Koh YW, Han JH, Yoon DH, Suh C, Huh J (2017) PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma. Ann Hematol 96(11):1883\u20131890. doi: https:\/\/doi.org\/10.1007\/s00277-017-3115-6","journal-title":"Ann Hematol"},{"key":"8113_CR38","doi-asserted-by":"publisher","unstructured":"Yajuk O, Baron M, Toker S, Zelter T, Fainsod-Levi T, Granot Z (2021) The PD-L1\/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer. Cells. 2021 10(6):1510. doi: https:\/\/doi.org\/10.3390\/cells10061510","DOI":"10.3390\/cells10061510"},{"key":"8113_CR39","doi-asserted-by":"crossref","unstructured":"Nita M, Grzybowski A (2016) The Role of the Reactive Oxygen Species and Oxidative Stress in the Pathomechanism of the Age-Related Ocular Diseases and Other Pathologies of the Anterior and Posterior Eye Segments in Adults. Oxid Med Cell Longev 2016: 3164734","DOI":"10.1155\/2016\/3164734"},{"key":"8113_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/0301-4738.178145","volume":"64","author":"CS Tan","year":"2016","unstructured":"Tan CS, Chew MC, Lim LW, Sadda SR (2016) Advances in retinal imaging for diabetic retinopathy and diabetic macular edema. Indian J Ophthalmol 64:76\u201383","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"8113_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3961\/jpmph.2011.44.4.157","volume":"44","author":"S Biswas","year":"2011","unstructured":"Biswas S, Raman R, Koluthungan V, Sharma T (2011) Intraocular Pressure and Its Determinants in Subjects With Type 2 Diabetes Mellitus in India. J Prev Med Public Health 44(4):157\u2013166","journal-title":"J Prev Med Public Health"},{"key":"8113_CR42","doi-asserted-by":"crossref","unstructured":"Lorenzi M (2007) The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp Diabetes Res 2007: 61038","DOI":"10.1155\/2007\/61038"},{"key":"8113_CR43","doi-asserted-by":"crossref","unstructured":"Safi SZ, Qvist R, Kumar S, Batumalaie K, Ismail IS (2014) Bin Molecular Mechanisms of Diabetic Retinopathy, General Preventive Strategies, and Novel Therapeutic Targets. Biomed Res Int 2014: 801269","DOI":"10.1155\/2014\/801269"},{"key":"8113_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fphar.2012.00087","volume":"3","author":"W Tang","year":"2012","unstructured":"Tang W, Martin KA, Hwa J (2012) Aldose Reductase, Oxidative Stress, and Diabetic Mellitus. Front Pharmacol 3:87","journal-title":"Front Pharmacol"},{"key":"8113_CR45","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/cns.13610","volume":"27","author":"V Castelli","year":"2021","unstructured":"Castelli V, Paladini A, d\u2019Angelo M (2021) Taurine and oxidative stress in retinal health and disease. CNS Neurosci Ther 27:403\u2013412","journal-title":"CNS Neurosci Ther"},{"key":"8113_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10571-012-9901-8","volume":"33","author":"MS Ola","year":"2013","unstructured":"Ola MS, Nawaz MI, El-Asrar AA, Abouammoh M, Alhomida AS (2013) Reduced levels of brain-derived neurotrophic factor (BDNF) in the serum of diabetic retinopathy patients and the retina of diabetic rats. Cell Mol Neurobiol 33:359\u2013367","journal-title":"Cell Mol Neurobiol"},{"key":"8113_CR47","first-page":"1","volume":"6","author":"AK Gond","year":"2017","unstructured":"Gond AK, Gupta SK (2017) Diabetic Retinopathy: Role of Traditional Medicinal Plants in its management and their molecular mechanism. Int J Pharm Sci Invent 6:1\u201314","journal-title":"Int J Pharm Sci Invent"},{"key":"8113_CR48","doi-asserted-by":"crossref","unstructured":"Kowluru RA, Chan PS (2007) Oxidative stress and diabetic retinopathy. Exp Diabetes Res 2007: 43603","DOI":"10.1155\/2007\/43603"},{"key":"8113_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12177-013-9104-7","volume":"5","author":"S Saxena","year":"2012","unstructured":"Saxena S, Mishra A, Saxena A, Natu SM (2012) Advanced glycation end products and diabetic retinopathy. J Ocul Biol Dis Infor 5:63\u201369","journal-title":"J Ocul Biol Dis Infor"},{"key":"8113_CR50","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.2337\/diabetes.53.11.2960","volume":"53","author":"L Zheng","year":"2004","unstructured":"Zheng L, Szabo C, Kern TS (2004) Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 53:2960\u20132967","journal-title":"Diabetes"},{"key":"8113_CR51","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.ajpath.2021.01.016","volume":"191","author":"RP Homme","year":"2021","unstructured":"Homme RP, Sandhu HS, George AK, Tyagi SC, Singh M (2021) Sustained Inhibition of NF-\u03baB Activity Mitigates Retinal Vasculopathy in Diabetes. Am J Pathol 191:947\u2013964","journal-title":"Am J Pathol"},{"key":"8113_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","volume":"10","author":"W Lan","year":"2012","unstructured":"Lan W, Petznick A, Heryati S, Rifada M, Tong L (2012) Nuclear Factor-\u03baB: central regulator in ocular surface inflammation and diseases. Ocul Surf 10:137\u2013148","journal-title":"Ocul Surf"},{"key":"8113_CR53","first-page":"445","volume":"66","author":"H Chakravarthy","year":"2018","unstructured":"Chakravarthy H, Devanathan V (2018) Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets. Int J Mol Sci 66:445\u2013461","journal-title":"Int J Mol Sci"},{"key":"8113_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.2174\/1874364101307010004","volume":"7","author":"N Gupta","year":"2013","unstructured":"Gupta N, Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonzadeh P, Kuppermann B, Kenney M (2013) Diabetic retinopathy and VEGF. Open Ophthalmol J 7:4\u201310","journal-title":"Open Ophthalmol J"},{"key":"8113_CR55","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1167\/iovs.04-1409","volume":"46","author":"GR Barile","year":"2005","unstructured":"Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL et al (2005) The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 46:2916\u20132924","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8113_CR56","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1167\/iovs.10-5881","volume":"51","author":"AW Stitt","year":"2010","unstructured":"Stitt AW (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51:4867\u20134874","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8113_CR57","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","volume":"290","author":"MG Buse","year":"2006","unstructured":"Buse MG (2006) Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290:E1\u2013E8","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"8113_CR58","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1172\/JCI118349","volume":"96","author":"AD Baron","year":"1995","unstructured":"Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT (1995) Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 96:2792\u20132801","journal-title":"J Clin Invest"},{"key":"8113_CR59","doi-asserted-by":"publisher","first-page":"14764","DOI":"10.1074\/jbc.M201056200","volume":"277","author":"KO Broschat","year":"2002","unstructured":"Broschat KO, Gorka C, Page JD, Martin-Berger CL, Davies MS, Huang HC, Gulve EA, Salsgiver WJ, Kasten TP (2002) Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I. Potent feedback inhibition by glucosamine 6-phosphate. J Biol Chem 277:14764\u201314770","journal-title":"J Biol Chem"},{"key":"8113_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/0974-9233.154386","volume":"22","author":"M Coucha","year":"2015","unstructured":"Coucha M, Elshaer SL, Eldahshan WS, Mysona BA, El-Remessy AB (2015) Molecular mechanisms of diabetic retinopathy: Potential therapeutic targets. Middle East Afr J Ophthalmol 22:135\u2013144","journal-title":"Middle East Afr J Ophthalmol"},{"key":"8113_CR61","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319\u20131331","journal-title":"Circ Res"},{"key":"8113_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.exer.2005.01.025","volume":"81","author":"Q Zhu","year":"2005","unstructured":"Zhu Q, Xu X, Xia X, Gu Q, Ho PC (2005) Role of protein kinase C on the alteration of retinal endothelin-1 in streptozotocin-induced diabetic rats. Exp Eye Res 81:200\u2013206","journal-title":"Exp Eye Res"},{"key":"8113_CR63","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.biocel.2005.08.002","volume":"38","author":"JL Wilkinson-Berka","year":"2006","unstructured":"Wilkinson-Berka JL (2006) Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol 38:752\u2013765","journal-title":"Int J Biochem Cell Biol"},{"key":"8113_CR64","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2337\/dc13-2002","volume":"37","author":"R Sim\u00f3","year":"2014","unstructured":"Sim\u00f3 R, Sundstrom JM, Antonetti DA (2014) Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy. Diabetes Care 37:893\u2013899","journal-title":"Diabetes Care"},{"key":"8113_CR65","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/279636a0","volume":"279","author":"KS Sakariassen","year":"1979","unstructured":"Sakariassen KS, Bolhuis PA, Sixma JJ (1979) Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature 279:636\u2013638","journal-title":"Nature"},{"key":"8113_CR66","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1167\/iovs.11-9102","volume":"53","author":"JG Lee","year":"2012","unstructured":"Lee JG, Kay EP (2012) NF-\u03baB is the transcription factor for FGF-2 that causes endothelial mesenchymal transformation in the cornea. Invest Ophthalmol Vis Sci 53:1530\u20131538","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"8113_CR67","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3390\/cancers12113285","volume":"12","author":"L Quatrini","year":"2020","unstructured":"Quatrini L, Mariotti FR, Munari E, Tumino N, Vacca P, Moretta L (2020) The Immune Checkpoint PD-1 in Natural Killer Cells: Expression, Function, and Targeting in Tumour Immunotherapy. Cancers (Basel) 12:3285. doi: https:\/\/doi.org\/10.3390\/cancers12113285","journal-title":"Cancers (Basel)"},{"key":"8113_CR68","doi-asserted-by":"publisher","first-page":"5918","DOI":"10.3390\/ijms21165918","volume":"21","author":"A Bocanegra","year":"2020","unstructured":"Bocanegra A, Blanco E, Fernandez-Hinojal G, Arasanz H, Chocarro L, Zuazo M, Morente P, Vera R, Escors D, Kochan G (2020) PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1\/PD-L1 Blockade Immunotherapy. Int J Mol Sci 21:5918. doi: https:\/\/doi.org\/10.3390\/ijms21165918","journal-title":"Int J Mol Sci"},{"key":"8113_CR69","doi-asserted-by":"publisher","first-page":"e108662","DOI":"10.15252\/embj.2021108662","volume":"40","author":"MP Kummer","year":"2021","unstructured":"Kummer MP, Ising C, Kummer C, Sarlus H, Griep A, Vieira-Saecker A, Schwartz S et al (2021) Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer\u2019s disease pathology. EMBO J 40:e108662. DOI: https:\/\/doi.org\/10.15252\/embj.2021108662","journal-title":"EMBO J"},{"key":"8113_CR70","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.4049\/jimmunol.1401572","volume":"193","author":"S Ostrand-Rosenberg","year":"2014","unstructured":"Ostrand-Rosenberg S, Horn LA, Haile ST (2014) The programmed death-1 immune-suppressive pathway: a barrier to antitumor immunity. J Immunol 193:3835\u20133841. doi: https:\/\/doi.org\/10.4049\/jimmunol.1401572","journal-title":"J Immunol"},{"key":"8113_CR71","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.7150\/jca.19060","volume":"8","author":"G Botti","year":"2017","unstructured":"Botti G, Scognamiglio G, Marra L, Pizzolorusso A, Di Bonito M, De Cecio R et al (2017) Programmed Death Ligand 1 (PD-L1) Expression in Primary Angiosarcoma. J Cancer 8:3166\u20133172. doi: https:\/\/doi.org\/10.7150\/jca.19060","journal-title":"J Cancer"},{"key":"8113_CR72","doi-asserted-by":"publisher","first-page":"598877","DOI":"10.3389\/fimmu.2020.598877","volume":"11","author":"SP Hack","year":"2020","unstructured":"Hack SP, Zhu AX, Wang Y (2020) Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1\/PD-L1 Pathways: Challenges and Opportunities. Front Immunol 11:598877. DOI: https:\/\/doi.org\/10.3389\/fimmu.2020.598877","journal-title":"Front Immunol"},{"key":"8113_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.molmed.2014.10.009","volume":"21","author":"KC Ohaegbulam","year":"2015","unstructured":"Ohaegbulam KC, Assal A, Lazar-Molnar E, Yao Y, Zang X (2015) Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends Mol Med 21:24\u201333. DOI: https:\/\/doi.org\/10.1016\/j.molmed.2014.10.009","journal-title":"Trends Mol Med"},{"key":"8113_CR74","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9","volume":"32","author":"L Carter","year":"2002","unstructured":"Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T et al (2002) PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 32:634\u2013643","journal-title":"Eur J Immunol"},{"key":"8113_CR75","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.semcancer.2013.12.005","volume":"25","author":"J Harper","year":"2014","unstructured":"Harper J, Sainson RC (2014) Regulation of the anti-tumor immune response by cancer-associated fibroblasts. Semin Cancer Biol 25:69\u201377. DOI: https:\/\/doi.org\/10.1016\/j.semcancer.2013.12.005","journal-title":"Semin Cancer Biol"},{"issue":"6","key":"8113_CR76","doi-asserted-by":"publisher","first-page":"1015e","DOI":"10.1097\/PRS.0b013e3182a806f0","volume":"132","author":"MA Mart\u00ednez-Jim\u00e9nez","year":"2013","unstructured":"Mart\u00ednez-Jim\u00e9nez MA, Aguilar-Garc\u00eda J, Vald\u00e9s-Rodr\u00edguez R, Metlich-Medlich MA, Dietsch LJP, Gait\u00e1n-Gaona FI, Kolosovas-Machuca ES, Gonz\u00e1lez FJ, S\u00e1nchez-Aguilar JM (2013) Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and angiogenesis. Plast Reconstr Surg 132(6):1015e\u20131019e. doi: https:\/\/doi.org\/10.1097\/PRS.0b013e3182a806f0","journal-title":"Plast Reconstr Surg"},{"issue":"5","key":"8113_CR77","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/156800911795655958","volume":"11","author":"R Tammali","year":"2011","unstructured":"Tammali R, Srivastava SK, Ramana KV (2011) Targeting aldose reductase for the treatment of cancer. Curr Cancer Drug Targets 11(5):560\u2013571. doi:https:\/\/doi.org\/10.2174\/156800911795655958","journal-title":"Curr Cancer Drug Targets"},{"key":"8113_CR78","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.2337\/diab.46.9.1473","volume":"46","author":"LP Aiello","year":"1997","unstructured":"Aiello LP, Bursell SE, Clermont A, Duh E, Ishii H, Takagi C (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46:1473\u20131480","journal-title":"Diabetes"},{"key":"8113_CR79","doi-asserted-by":"crossref","unstructured":"Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY et al (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes: 57, 460-9","DOI":"10.2337\/db07-1119"},{"key":"8113_CR80","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2174\/138920111794480606","volume":"12","author":"MI G\u00e1lvez","year":"2011","unstructured":"G\u00e1lvez MI (2011) Protein kinase C inhibitors in the treatment of diabetic retinopathy. Rev Curr Pharm Biotechnol 12:386\u2013391","journal-title":"Rev Curr Pharm Biotechnol"},{"key":"8113_CR81","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/jop.2005.21.95","volume":"21","author":"IM Fang","year":"2005","unstructured":"Fang IM, Yang CH, Lin CP, Yang CM, Chen MS (2005) Effects of pyrrolidine dithiocarbamate, an NF-kappaB inhibitor, on cytokine expression and ocular inflammation in experimental autoimmune anterior uveitis. J Ocul Pharmacol Ther 21:95\u2013106","journal-title":"J Ocul Pharmacol Ther"},{"key":"8113_CR82","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/15376516.2014.898355","volume":"24","author":"K Shekh","year":"2014","unstructured":"Shekh K, Khan S, Jena G, Kansara BR, Kushwaha S (2014) 3-Aminobenzamide\u2013a PARP inhibitor enhances the sensitivity of peripheral blood micronucleus and comet assays in mice. Toxicol Mech Methods 24:332\u2013341","journal-title":"Toxicol Mech Methods"},{"key":"8113_CR83","first-page":"44","volume":"118","author":"G Malukiewicz","year":"2016","unstructured":"Malukiewicz G, Stafiej J, Lesiewska H, Sikorski B (2016) Use of nonsteroidal anti-inflammatory drugs in diabetic retinopathy. Klin Oczna 118:44\u201347","journal-title":"Klin Oczna"},{"key":"8113_CR84","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/jdi.12272","volume":"6","author":"M Kondo","year":"2015","unstructured":"Kondo M, Kamiya H, Himeno T (2015) Therapeutic efficacy of bone marrow-derived mononuclear cells in diabetic polyneuropathy is impaired with aging or diabetes. J Diabetes Investig 6:140\u2013149","journal-title":"J Diabetes Investig"},{"key":"8113_CR85","doi-asserted-by":"publisher","first-page":"144","DOI":"10.5607\/en.2011.20.3.144","volume":"20","author":"HS Hwang","year":"2011","unstructured":"Hwang HS, Yang EJ, Lee SM, Lee SC, Choi SM (2011) Antiallodynic Effects of Electroacupuncture Combined with MK-801 Treatment through the Regulation of p35\/p25 in Experimental Diabetic Neuropathy. Exp Neurobiol 20:144\u2013152","journal-title":"Exp Neurobiol"},{"key":"8113_CR86","first-page":"177","volume":"22","author":"V Gogia","year":"2012","unstructured":"Gogia V, Khanduja S, Gupta S, Kakkar A, Majumdar S, Garg SP, Vohra R (2012) Vitrectomy in Diabetic Retinopathy. DJO 22:177\u2013182","journal-title":"DJO"},{"issue":"4","key":"8113_CR87","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s11427-020-1740-8","volume":"64","author":"W Zhai","year":"2021","unstructured":"Zhai W, Zhou X, Zhai M, Li W, Ran Y, Sun Y, Du J, Zhao W, Xing L, Qi Y, Gao Y (2021) Blocking of the PD-1\/PD-L1 interaction by a novel cyclic peptide inhibitor for cancer immunotherapy. Sci China Life Sci 64(4):548\u2013562. DOI: https:\/\/doi.org\/10.1007\/s11427-020-1740-8","journal-title":"Sci China Life Sci"},{"key":"8113_CR88","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.arr.2022.101560","volume":"75","author":"SP Panda","year":"2022","unstructured":"Panda SP, Soni U (2022) A review of dementia, focusing on the distinct roles of viral protein corona and MMP9 in dementia: Potential pharmacotherapeutic priorities. Ageing Res Rev 75:101560. https:\/\/doi.org\/10.1016\/j.arr.2022.101560","journal-title":"Ageing Res Rev"},{"issue":"9","key":"8113_CR89","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/ceo.13864","volume":"48","author":"Y Zheng","year":"2020","unstructured":"Zheng Y, Sun Q, Xu X, Wang W (2020) Novel peptide derived from IGF-2 displays anti-angiogenic activity in vitro and inhibits retinal angiogenesis in a model of oxygen-induced retinopathy. Clin Exp Ophthalmol 48(9):1261\u20131275. https:\/\/doi.org\/10.1111\/ceo.13864","journal-title":"Clin Exp Ophthalmol"},{"key":"8113_CR90","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.mvr.2018.08.002","volume":"122","author":"K Palanisamy","year":"2019","unstructured":"Palanisamy K, Nareshkumar RN, Sivagurunathan S, Raman R, Sulochana KN, Chidambaram S (2019) Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells. Microvasc Res 122:136\u2013145. https:\/\/doi.org\/10.1016\/j.mvr.2018.08.002","journal-title":"Microvasc Res"},{"key":"8113_CR91","doi-asserted-by":"publisher","first-page":"107823","DOI":"10.1016\/j.exer.2019.107823","volume":"190","author":"J Jiang","year":"2020","unstructured":"Jiang J, Wang L, Kou X et al (2020) In vivo characterization of RC28-E, a fusion protein targeting VEGF and bFGF: pharmacokinetics and ocular distribution in primates. Exp Eye Res 190:107823. https:\/\/doi.org\/10.1016\/j.exer.2019.107823","journal-title":"Exp Eye Res"},{"key":"8113_CR92","doi-asserted-by":"publisher","unstructured":"Yin X, Lin X, Ren X et al (2019) Novel multi-targeted inhibitors sup-press ocular neovascularization by regulating unique gene sets. Pharmacol Res.146: 104277. https:\/\/doi.org\/10.1016\/j.phrs.2019.104277","DOI":"10.1016\/j.phrs.2019.104277"},{"issue":"373","key":"8113_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aai8030","volume":"9","author":"R Lima e Silva","year":"2017","unstructured":"Lima e Silva R, Kanan Y, Mirando AC et al (2017) Tyrosine kinase blocking collagen IV- derived peptide suppresses ocular neovascularization and vascular leakage. Sci Transl Med 9(373):1\u201312. https:\/\/doi.org\/10.1126\/scitranslmed.aai8030","journal-title":"Sci Transl Med"},{"key":"8113_CR94","doi-asserted-by":"publisher","first-page":"107798","DOI":"10.1016\/j.exer.2019.107798","volume":"188","author":"N Sheibani","year":"2019","unstructured":"Sheibani N, Wang S, Darjatmoko SR et al (2019) Novel anti-angiogenic VEGF-derived small peptides mitigate choroidal neovascularization. Exp Eye Res 188:107798","journal-title":"Exp Eye Res"},{"key":"8113_CR95","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.omtm.2019.10.013","volume":"15","author":"M Hernandez","year":"2019","unstructured":"Hernandez M, Recalde S, Garcia-Garcia L et al (2019) Preclinical evaluation of a cell-based gene therapy using the sleeping beauty transposon system in choroidal neovascularization. Mol Ther Methods Clin Dev 15:403\u2013417. https:\/\/doi.org\/10.1016\/j.omtm.2019.10.013","journal-title":"Mol Ther Methods Clin Dev"},{"key":"8113_CR96","doi-asserted-by":"publisher","first-page":"e921184","DOI":"10.12659\/MSM.921184","volume":"26","author":"Z Wang","year":"2020","unstructured":"Wang Z, Gao F, Zhang M et al (2020) Intravitreal injection of human retinal progenitor cells for treatment of retinal degeneration. Med Sci Monit 26:e921184. https:\/\/doi.org\/10.12659\/MSM.921184","journal-title":"Med Sci Monit"},{"key":"8113_CR97","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/j.omtn.2019.07.018","volume":"17","author":"Y Matsuda","year":"2019","unstructured":"Matsuda Y, Nonaka Y, Futakawa S et al (2019) Antiangiogenic and anti-scarring dual action of an anti-fibroblast growth factor 2 aptamer in animal models of retinal disease. Mol Ther Nucleic Acids 17:819\u2013828. https:\/\/doi.org\/10.1016\/j.omtn.2019.07.018","journal-title":"Mol Ther Nucleic Acids"},{"key":"8113_CR98","doi-asserted-by":"publisher","first-page":"107977","DOI":"10.1016\/j.exer.2020.107977","volume":"193","author":"O Vivanco Rojas","year":"2020","unstructured":"Vivanco Rojas O, Garc\u00eda- Berm\u00fadez MY, Iturriaga Goyon E et al (2020) Corneal neovascularization is inhibited with nucleolin binding aptamer, AS1411. Exp Eye Res 193:107977","journal-title":"Exp Eye Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08113-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08113-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T13:58:03Z","timestamp":1675346283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08113-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["8113"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08113-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"23 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors read and approved the final manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}